通过B7RP-1和ICOS进行T细胞共刺激
S K Yoshinaga1, J S Whoriskey, S D Khare
1Amgen Inc., Thousand Oaks, California 91320, USA. syoshina@amgen.com
Nature
|January 5, 2000
概括
发现了一种新的共刺激受体ICOS及其连接体B7相关蛋白-1 (B7RP-1). 这种独特的途径调节T细胞激活和适应性免疫,独立于CD28-B7相互作用.
科学领域:
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- T细胞激活依赖于通过CD28等受体的共同刺激和通过T细胞受体的抗原特异信号传递.
- 研究了一种与CD28-B7通路相关的新型共刺激受体-连接体对.
研究的目的:
- 识别和描述一种参与T细胞激活的新型共刺激性受体-连接体对.
- 阐明ICOS和B7RP-1在适应性免疫反应中的作用.
主要方法:
- 识别和表征ICOS受体及其连接体B7RP-1.
- 使用B7RP-1进行T细胞的体外同刺激试验.
- 在体内研究使用表达B7RP-1-Fc融合蛋白的转基因小鼠和用B7RP-1-Fc治疗的敏感小鼠.
主要成果:
- 新型受体ICOS在激活和记忆T细胞上表达,而它的配体B7RP-1在B细胞和巨细胞上发现.
- ICOS和B7RP-1的功能独立于CD28-B7通路,而B7RP-1在体外显示T细胞共刺激.
- 转基因小鼠表现出淋巴细胞增生,而接受治疗的小鼠表现出增强的过敏性,表明体内共刺激活性.
结论:
- ICOS和B7RP-1构成了一种新的,独特的共刺激性受体-连接体对,其结构与CD28-B7.7有关.
- 这一途径在调节T细胞反应和适应性免疫系统方面发挥着重要作用.
相关概念视频
Cell-mediated Immune Responses
65.0K
Overview
65.0K
Antigen Presenting Cells
3.8K
The immune system is a complex network of cells and molecules that protects the body from foreign invaders. T cells, a type of white blood cell, play a crucial role in this process. They recognize and attack foreign substances, such as pathogens, that enter the body.
T cells require the help of antigen-presenting cells (APCs), which process foreign antigens into smaller fragments that can be recognized by T cells. These APCs are highly specialized cells that efficiently internalize antigens...
T cells require the help of antigen-presenting cells (APCs), which process foreign antigens into smaller fragments that can be recognized by T cells. These APCs are highly specialized cells that efficiently internalize antigens...
3.8K
T Cell Activation and Clonal Selection
13.7K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
13.7K
Cytotoxic T Cells-mediated Immune Response
7.1K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.1K
B Cell Activation and Differentiation
14.6K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
14.6K
Tumor Immunotherapy
2.6K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.6K


